Call Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
4. Presbycusis.pptx
1.
2. Presbycusis, or age-related hearing loss (ARHL),
is the loss of hearing that gradually occurs in most
people as they grow older.
According to theWorld Health Organization,
approximately one third of people over 65 years of
age are affected by disabling hearing loss.
In 2025, there will be 1.2 billion people over 60
years of age worldwide, with more than 500 million
individuals who will suffer significant impairment
from presbycusis
5. ARHL is a progressive, irreversible, and symmetrical
bilateral neuro-sensory hearing loss resulting either
from
• degeneration of the cochlea , or
• loss of auditory nerve fibers during cochlear aging
associated with difficulty in speech discrimination, as
well as in sound detection and localization, particularly
in noise.
Males are generally more severely affected than
females
Untreated presbycusis can contribute to social
isolation, depression, and dementia
6. Increases with age.
25 – 30% of people aged 65 – 75 are
estimated to have impaired hearing.
For people aged 75 or older incidence is
thought to be 40 – 50%
7. Presbycusis is a multifactorial condition
that represents the lifetime accumulation of
both intrinsic and extrinsic insults on the
inner ear, including the inner and outer hair
cells, stria vascularis, and afferent spiral
ganglion neurons
8. Four primary categories of risk factors for
presbycusis:
1. Cochlear aging,
2. Noise exposure,
3. Genetic predisposition, and
4. Health comorbidities
9. Increasing Age
• strong, consistent association
• Increased mutations and deletions in mitochondrial DNA
Noise
• Reactive oxygen species are believed to play a major role in
cochlear aging, and they are also generated in response to noise
exposure.
Genetic Predisposition
• Male sex and race
• blacks consistently demonstrate 60% to 70% lower odds of
hearing loss compared with whites
• Presbycusis has been found to cluster strongly in families.
• more pronounced for the strial atrophy pattern of hearing loss (flat
audiogram) than the sensory phenotype (high-frequency loss)
• Proposed genes in recent studies include those that code for
glutathione peroxidase and superoxide dismutase, two
antioxidant enzymes active in the cochlea
Health Comorbidities
• smoking and circulatory disorders such as hypertension,
cardiovascular and cerebrovascular disease, and diabetes
10. Histologic changes associated with aging
occur throughout the auditory system from
the hair cells of the cochlea to the auditory
cortex in temporal lobe of the brain.
Elucidation of pathophysiology of
presbycusis is still incomplete.
11. Studied histologic changes in cochlea of
human ears with presbycusis
Identified 4 sites of aging in cochlea and
divided presbycusis into 4 types based on
these sites
Histologic changes correlated
approximately with symptoms and auditory
test results
12. Epithelial atrophy with loss of sensory hair cells
as well as supporting cells in the organ of corti.
Originates in basal turn of cochlea and slowly
progress towards the apex. Affects first few
millimeters of basal turn.
Sharp drop in high frequency threshold, begins
after
middle age.
Abrupt downward slope of audiogram begins
above
speech frequency, speech discrimination is
preserved.
13. Histologically atrophy
may be limited to only
the first few millimetres
of basal end of cochlea
Process is slowly
progressive over time
Due to accumulation
of lipofuscin pigment
granules at the basal
end of cochlea
14. Most common type.
Atrophy of the spiral ganglion and nerves of
osseous spiral lamina in the basal turn
Organ of Corti is largely intact
Schuknecht estimated that 2100/35000
neurons are lost every decade. Loss begins
early in life and may be genetically
predetermined.
Effects not noticeable until old age because
PTA not affected until 90% of neurons are
gone.
15. Gradual hearing loss
with moderate slope in
high frequencies
Disproportionate
decline in speech
discrimination
Often refractory to
amplification
May be observed
before hearing loss is
noted because fewer
neurons are required to
maintain speech
thresholds than speech
discrimination
16. Results as atrophy of stria
vascularis.
Normally maintains the chemical
and bioelectrical balance and
metabolic health of cochlea
Hearing is represented by a flat
hearing curve because entire
cochlea is affected
Speech discrimination is
preserved
Affects younger population (30 –
60 years) with slow progression
and may be familial
17. Atrophy of the spiral ligament
Primarily affects the apical
turn
Cystic degeneration may
cause detachment of the
organ of Corti from the lateral
cochlear wall
Bilateral symmetric loss with
upward slope in high
frequencies
Preserved speech
discrimination
18. Change in characteristics of the cochlear duct that
are
not evident on light microscopy but alter function
at
sub microscopic level.
Changes in intracellular organalles involved in cell
metabolism,decrease in synapse numbers and
changes
in endolymph composition have all been
implicated in
this category.
20. Presentation varies
Physological -Old patient at least in their
fifties.
H/O :Slow and insidious hearing problem
Description involves loss of clarity rather than
loss of volume.
Difficulty in hearing conversation particularly
in presence of background noise.
Sometimes tinnitus may be the only
presenting
feature.
22. Audiology with PTA and
speech discrimination
Most commonly, the
audiogram shows a hearing
loss which tend to be worse
at higher frequency.
As the condition advances
there tends to be progressive
loss of be loss of middle( 1
and 2 KHz) and even low
frequencies.(250 & 500hz).
23. Age >60yrs.
Normal examination finding.
Symmetrical
High frequency hearing loss.
27. recent emphasis has been placed on personal
sound amplification products (PSAPs) and low-
cost, community-based hearing interventions for
older adults.
Aside from amplification, correction of health
factors that may impact age-related hearing
loss—such as smoking, hypertension, and
cholesterol levels—should also be considered.
Cochlear implantation may play a role in treating
older adults with severe to profound sensorineural
deafness.